Recent CARM News
- Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer • PR Newswire (US) • 05/02/2024 11:30:00 AM
- Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting • PR Newswire (US) • 04/24/2024 09:05:00 PM
- Carmila : Lancement d’un programme de rachat d’actions pour 10 millions d’euros • Business Wire • 04/24/2024 04:43:00 PM
- Carmila: Launch of a Share Buyback Program for €10 Million • Business Wire • 04/24/2024 04:43:00 PM
- Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting • PR Newswire (US) • 04/22/2024 08:35:00 PM
- Carmila : Information financière au 31 mars 2024 • Business Wire • 04/17/2024 03:45:00 PM
- Carmila: First-quarter 2024 Financial Information • Business Wire • 04/17/2024 03:45:00 PM
- Carmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers • Business Wire • 04/05/2024 03:45:00 PM
- Carmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiers • Business Wire • 04/05/2024 03:45:00 PM
- Carisma Therapeutics to Present at Upcoming Conferences • PR Newswire (US) • 04/03/2024 11:00:00 AM
- Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 04/01/2024 12:35:00 PM
- Carisma Therapeutics Announces Changes to its Board of Directors • PR Newswire (US) • 04/01/2024 11:00:00 AM
- Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 03/21/2024 09:00:00 PM
- INFORMATION RELATIVE A LA REMUNERATION DES DIRIGEANTS MANDATAIRES SOCIAUX • Business Wire • 03/15/2024 04:45:00 PM
- Carmila : Communiqué de mise à disposition du Document d’enregistrement universel 2023 • Business Wire • 03/15/2024 04:45:00 PM
- Carmila: Filing of the 2023 Universal Registration Document • Business Wire • 03/15/2024 04:45:00 PM
- Carmila: Information Relating to Executive Corporate Officer Compensation • Business Wire • 03/15/2024 04:45:00 PM
- Carmila : Evolution de la composition du Conseil d’administration suite au Conseil d’administration du 7 mars 2024 • Business Wire • 03/08/2024 04:45:00 PM
- CORRECTING and REPLACING: Carmila: Changes in the composition of the Board of Directors following the meeting of the Board of Directors on 7 March 2024 • Business Wire • 03/08/2024 04:45:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 09:05:27 PM
- Evolution de la composition du Conseil d’administration suite au Conseil d’administration du 7 mars 2024 • Business Wire • 03/07/2024 06:13:00 PM
- Changes in the composition of the Board of Directors following the meeting of the Board of Directors on 7 March 2024 • Business Wire • 03/07/2024 06:13:00 PM
- Carmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers • Business Wire • 03/04/2024 04:45:00 PM
- Carmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiers • Business Wire • 03/04/2024 04:45:00 PM
- Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference • PR Newswire (US) • 02/28/2024 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM